High prevalence of disabling hearing loss in young to middle-aged adults with diabetes

Hlayisi, Vera-Genevey; Petersen, Lucretia; Ramma, Lebogang

doi:10.1007/s13410-018-0655-9

Cited by 13 publications

(26 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The high frequency of hearing loss in our study, among the highest reported, 1 could be attributed to the relatively high mean age and complicated diabetes of the patients we studied. The 29% prevalence of disabling hearing loss is higher than that reported by the WHO in the Middle East and North Africa (3.5%).…”

Section: Discussionmentioning

confidence: 51%

“…These findings are inconsistent with those reported in other ethnicities. 1 The remaining 10% of the cases had either severe or profound hearing loss; this proportion is still higher than that reported by the WHO in the Middle East. 7 In this study, hearing loss was more prevalent among older patients and among men, which is consistent with the findings of different cross-sectional and prospective studies investigating hearing loss.…”

Section: Discussionmentioning

confidence: 77%

“…There is little awareness of hearing loss as a possible comorbid condition associated with type 2 diabetes among persons with diabetes as well as healthcare professionals, despite several studies having demonstrated the link between the two clinical conditions. 1 More than 43% of diabetes patients are likely to have some degree of hearing impairment related or unrelated to chronic hyperglycemia. 2 There is a requirement for further studies for the exploration of the relationship between diabetes and hearing abnormalities.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Hearing loss among patients with type 2 diabetes mellitus: a cross-sectional study

Al‐Rubeaan¹,

Al-momani

AlGethami

et al. 2021

Ann Saudi Med

View full text Add to dashboard Cite

BACKGROUND: Hearing loss is an underestimated comorbid condition in type 2 diabetes. OBJECTIVES: Investigate hearing loss as a comorbidity associated with type 2 diabetes mellitus and evaluate the factors associated with hearing loss. DESIGN: Cross-sectional. SETTING: Tertiary care center, diabetes clinic. PATIENTS AND METHODS: Patients with type 2 diabetes, aged 30 to 60 years, were randomly selected to participate. All patients underwent clinical ear examinations and were referred for full audiological evaluation. Otoacoustic emission was used to assess inner function, tympanometry to assess middle-ear function, and pure tone air/bone audiometry to assess hearing sensitivity. Risk factors for hearing loss were assessed by multivariate logistic regression. MAIN OUTCOME MEASURE: Frequency, severity and risk factors for hearing loss. SAMPLE SIZE: 157 RESULTS: Of the 157 patients, 77 had hearing loss in both ears (49.0%), 13 in the right ear only (8.3%), 14 in the left ear only (8.9%), and 53 (33.8%) had normal hearing. In the 181 ears with sensorineural hearing loss, 90 had mild loss (49.7%), 69 moderate loss (38.2%), 16 severe loss (8.8%) and 6 had profound loss (3.3%). Disabling hearing loss was observed in 46 (29%) patients. A higher frequency of hearing loss was present in patients with glycated hemoglobin levels ≥8%. In the multivariate logistic regression analysis, the most important factors associated with hearing loss were longer diabetes duration, poor glycemic control and the presence of hypertension. CONCLUSIONS: Hearing loss is an underestimated comorbid condition in type 2 diabetes that warrants frequent hearing assessments and management. Strict glycemic and hypertension control is essential for the minimization of the effects of diabetes on hearing sensitivity. LIMITATIONS: Small sample size, limited age window (30-60 years), which was chosen to eliminate the natural aging effect on hearing. Cross-sectional nature was not ideal for the assessment of causality. CONFLICT OF INTEREST: None.

show abstract

Section: Discussionmentioning

confidence: 51%

Section: Discussionmentioning

confidence: 77%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Hearing loss among patients with type 2 diabetes mellitus: a cross-sectional study

Al‐Rubeaan¹,

Al-momani

AlGethami

et al. 2021

Ann Saudi Med

View full text Add to dashboard Cite

show abstract

“…The results of present study are comparble to studies conducted by Rajendran et al with prevalence 73.3% and Hlayisi et al with prevalence 74%. 5,6 However, low prevalence was seen in study by Nagoshi et al (54%) and Friedmann et al (55%). 7,8 Variation may seen in prevalence because of the different study period, sample size, inclusion and exclusion criteria.…”

Section: Discussionmentioning

confidence: 95%

Cross sectional study of sensorineural hearing loss in type 2 diabetes mellitus

Makwana¹,

Sharma

Vyas

et al. 2019

Int J Otorhinolaryngol Head Neck Surg

View full text Add to dashboard Cite

Background: The objective of the study was to evaluate the prevalence of sensorineural hearing loss in type 2 diabetes mellitus and to figure out a relation between age, sex, duration of diabetes and diabetic control.Methods: A cross-sectional study was conducted at Geetanjali Medical College and Hospital for 1.5 years. Patients were known case of diabetes mellitus type 2 without any other systemic illness included in the study. A total of 115 patients were involved in the study and the informed consent was taken. A detailed examination and history related to hearing loss and diabetes status with treatment was elicited. All basic blood investigations were performed on all the patients. All the patients were subjected to pure tone audiometry and impedance audiometry in a sound proof room. Results: The total prevalence of sensorineural hearing loss in the study subjects was found to be 80% with most of them having mild degree of sensorineural deafness. Increase in age, longer duration and uncontrolled diabetes are the factors which had higher risk of developing sensorineural hearing loss in the study subjects.Conclusions: There is a strong association between sensorineural hearing loss and duration of diabetes mellitus-2. The threshold of hearing loss is increased mainly at the higher frequencies with diabetes.

show abstract

“…8 The most significant finding was that 55% of persons under the age of 60 years in the study who presented with unexplained high frequency sensorineural hearing loss were diabetic than the non-diabetic group (9%). 9 A 2018 South African study 9 aimed to determine prevalence and to characterize the nature of hearing loss in patients with diabetes in South Africa. Findings of this study showed that participants who were diagnosed with diabetes had a higher proportion of disabling hearing loss when compared to those without diabetes.…”

Section: Prevalence Of Auditory-related Diabetes Drug Side Effectsmentioning

confidence: 99%

Auditory and Vestibular Side Effects of FDA-Approved Drugs for Diabetes

DiSogra

Meece

2019

Semin Hear

View full text Add to dashboard Cite

As of September 10, 2019, there were 75 medications (oral/injectable/inhalants) approved by the U.S. Food and Drug Administration for diabetes management: 1 inhalant, 21 oral combinations, 22 injectable, and 31 oral medications (not in combination with any other diabetes drug). This article isolates the auditory and vestibular side effects of those drugs as reported by the drug's manufacturer as well as those side effects that could interfere with a balance assessment. Twenty of the 75 approved medications (26%) could have an auditory-related side effect. Hearing loss and tinnitus are not on the list. Only two, or just 3%, have vertigo and spinning as reported side effects (one each). More than 50% of the drugs will have some effect on a balance assessment. Audiologists who evaluate a patient with diabetes (PWD) are presented with symptoms that could be related to their diabetes medication. Although the manufacturer might report a side effect as rare or as a percentage from their clinical trials subjects, not all PWD will experience these adverse events. Auditory and vestibular side effects do not dominate the diabetes drug side effect list, but, rather, the most reported side effects could impact a balance assessment. The lists that appear in Appendices A and B should serve as a guide for all professionals involved in managing the PWD (i.e., audiologists, otolaryngologists, diabetes educators, pharmacists, optometrists, dentists, etc.). The list also serves as a counseling tool if a communication problem emerges during the progression of the diabetes.

show abstract

High prevalence of disabling hearing loss in young to middle-aged adults with diabetes

Cited by 13 publications

References 18 publications

Hearing loss among patients with type 2 diabetes mellitus: a cross-sectional study

Hearing loss among patients with type 2 diabetes mellitus: a cross-sectional study

Cross sectional study of sensorineural hearing loss in type 2 diabetes mellitus

Auditory and Vestibular Side Effects of FDA-Approved Drugs for Diabetes

Contact Info

Product

Resources

About